BERLIN--(BUSINESS WIRE)--BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the Industry’s first European CE Mark approval for its unique remote patient monitoring technology. BIOTRONIK Home Monitoring® is now approved to safely replace in-hospital device follow-up visits. This new CE Mark follows the recently received equivalent FDA approval granted in May, 2009.
